image article

This article discusses the importance of hemoglobin screening in diagnosing and managing anemia, as well as its impact on anemia patients. Hemoglobin screening allows for early detection of anemia and ensures timely intervention. Through simple screening tests, doctors can identify anemia, assess its severity, and plan appropriate treatment. Additionally, hemoglobin screening is also useful in monitoring the effectiveness of anemia treatment and making necessary adjustments. With early detection and effective management, anemia patients can experience significant health improvements and enhance their quality of life.

Anemia is a common blood disorder characterized by a decrease in the number of red blood cells or a decrease in hemoglobin levels. It affects millions of people worldwide, leading to various health complications and reduced quality of life. Hemoglobin screening plays a crucial role in the early detection, diagnosis, and management of anemia. This article explores the significance of hemoglobin screening and its profound impact on individuals living with anemia.

The Importance of Hemoglobin Screening

Hemoglobin screening serves as an essential tool in identifying anemia and assessing its severity. By measuring the hemoglobin levels in the blood, healthcare professionals can accurately diagnose anemia and determine the appropriate course of treatment. Screening tests are relatively simple, cost-effective, and can be performed in various healthcare settings, making them accessible to a wide range of individuals.

Early Detection and Diagnosis: Screening for hemoglobin levels allows for early detection and diagnosis of anemia. Timely identification of the condition enables healthcare providers to initiate appropriate interventions promptly. Early intervention is crucial in preventing the progression of anemia and its associated complications. By identifying anemia in its early stages, healthcare professionals can address underlying causes, such as nutritional deficiencies, chronic diseases, or genetic factors, and tailor treatment plans accordingly.

Monitoring Treatment Effectiveness

Regular hemoglobin screening is essential in monitoring the effectiveness of treatment interventions for anemia. By tracking hemoglobin levels over time, healthcare providers can evaluate the response to therapy and make necessary adjustments. This helps ensure that the treatment is effectively addressing the underlying cause of anemia and promoting the production of healthy red blood cells. Adjustments in treatment can be made promptly to optimize outcomes and improve the overall well-being of the individual.

PT Isotekindo Intertama provides a POCT (Point Of Care Test) tool for checking Hemoglobin levels in the blood which is practical and convenient to use because it only requires a small sample (1µL). This is the first biosensor technology for screening hemoglobin In Indonesia, using HemoSmart GOLD Hemoglobin Screening Meter.

The features and other benefits are:

Impact on Anemia Patients

Hemoglobin screening has a significant impact on individuals living with anemia. Through early detection and monitoring, the screening process facilitates timely interventions, leading to improved health outcomes and enhanced quality of life. By identifying anemia early, patients can receive appropriate treatment, such as iron supplementation, dietary modifications, or in some cases, blood transfusions. Effective management of anemia can alleviate symptoms such as fatigue, weakness, and shortness of breath, allowing individuals to lead a more active and fulfilling life.



  1. Bilen, Ö., Gündüz, C., Kavas, G. Ö., & Ak, T. (2016). Iron deficiency anemia: an underestimated problem in pregnant women. North Clin Istanb, 3(3), 207-213.

  2. Insert Pack HemoSmart GOLD Hemoglobin Screening Meter.
  3. Milman, N. (2011). Anemia—still a major health problem in many parts of the world! Annals of Hematology, 90(4), 369-377.

  4. Pavord, S., Myers, B., Robinson, S., & Allard, S. (2012). UK guidelines on the management of iron deficiency in pregnancy. British Journal of Haematology, 156(5), 588-600.

  5. World Health Organization. (2011). Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. 

  6. Zakai, N. A., McClure, L. A., Prineas, R., Howard, G., & McClellan, W. (2009). Racial and regional differences in the association of anemia with outcomes for hospitalized stroke patients. Journal of Stroke and Cerebrovascular Diseases, 18(2), 140-147.

Hemoglobin & Hematocrit (Hb & Ht)
Related Articles